Nantahala Capital Management, LLC 13D and 13G filings for Zevra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:32 pm Sale |
2024-12-31 | 13G | Zevra Therapeutics, Inc. ZVRA |
Nantahala Capital Management, LLC | 2,340,333 4.380% |
-583,688 (-19.96%) |
Filing |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Zevra Therapeutics, Inc. ZVRA |
Nantahala Capital Management, LLC | 2,924,021 5.557% |
470,616 (+19.18%) |
Filing |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Zevra Therapeutics, Inc. ZVRA |
Nantahala Capital Management, LLC | 2,453,405 6.200% |
2,453,405 (New Position) |
Filing |